Tejnaksh Healthcare Ltd Stock Falls to 52-Week Low of Rs.12.1

Stock Price Movement and Market Context

On 4 Mar 2026, Tejnaksh Healthcare Ltd’s stock closed at Rs.12.1, down by 0.23% on the day. This new low comes after three consecutive days of losses, during which the stock has declined by 6.54%. Despite this, the stock marginally outperformed its sector, the Hospital & Healthcare Services segment, which fell by 3.14% on the same day. However, the broader market environment remains subdued, with the Sensex opening sharply lower by 1,710 points before recovering some ground to trade at 79,038.82, still down 1.5% for the session.

Tejnaksh Healthcare’s share price is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical positioning underscores the sustained downward momentum in the stock’s price action.

Long-Term Performance and Relative Comparison

Over the past year, Tejnaksh Healthcare Ltd has delivered a total return of -40.12%, a stark contrast to the Sensex’s positive return of 8.19% over the same period. The stock’s 52-week high was Rs.24.77, indicating a near 51% decline from its peak. This underperformance extends beyond the last year, with the company consistently lagging behind the BSE500 benchmark in each of the previous three annual periods.

Fundamental Metrics and Financial Health

Tejnaksh Healthcare Ltd’s fundamental profile continues to reflect challenges. The company’s long-term operating profit growth has been negative, with a compound annual growth rate (CAGR) of -5.68% over the last five years. This decline in operating profits is mirrored in the recent financial results, where profits fell by 41.2% over the past year.

The company’s average Return on Equity (ROE) stands at 9.52%, indicating relatively low profitability on shareholders’ funds. More recent data shows an ROE of 6.3%, which, while modest, contributes to the company’s valuation metrics. The stock currently trades at a Price to Book Value of 1, suggesting a valuation that is attractive relative to its peers, who generally command higher multiples historically.

However, the company’s debtor turnover ratio for the half-year period is notably low at 4.87 times, signalling slower collection of receivables and potential liquidity concerns. This metric is a key indicator in the healthcare services sector, where efficient working capital management is critical.

Sector and Market Position

Within the healthcare services sector, Tejnaksh Healthcare Ltd operates in a competitive environment. The sector itself has experienced a decline of 3.14% recently, reflecting broader pressures on hospital and healthcare service providers. Despite this, Tejnaksh’s underperformance relative to its sector peers is pronounced, as evidenced by its weaker stock price trajectory and financial metrics.

The company’s promoter group remains the majority shareholder, maintaining control over strategic decisions. This ownership structure can influence the company’s long-term direction and capital allocation policies.

Mojo Score and Analyst Ratings

Tejnaksh Healthcare Ltd’s current Mojo Score is 26.0, categorising it as a Strong Sell. This rating was upgraded from a Sell to Strong Sell on 9 Feb 2026, reflecting deteriorating fundamentals and market sentiment. The company’s Market Cap Grade is 4, indicating a relatively small market capitalisation within its sector.

The downgrade in rating aligns with the company’s consistent underperformance and weak financial indicators, including declining operating profits and subdued return metrics. These factors contribute to the cautious stance reflected in the Mojo Grade.

Summary of Key Financial and Market Indicators

To summarise, Tejnaksh Healthcare Ltd’s stock has reached a new 52-week low of Rs.12.1, continuing a downward trend that has seen the share price halve from its 52-week high of Rs.24.77. The stock’s performance over the last year has been significantly weaker than the broader market and its sector peers, with a total return of -40.12% compared to the Sensex’s 8.19% gain.

Financially, the company faces challenges with negative operating profit growth over five years, low debtor turnover, and modest profitability as measured by ROE. While the valuation appears attractive on a Price to Book basis, the underlying fundamentals and recent results have weighed on investor confidence.

Market conditions remain volatile, with the healthcare services sector also experiencing pressure. Tejnaksh Healthcare Ltd’s position within this environment is reflected in its strong sell rating and subdued market capitalisation grade.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today